Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Carter R, Wolf J, van Opijnen T, Muller M, Obert C, Burnham C, Mann B, Li Y, Hayden RT, Pestina T, Persons D, Camilli A, Flynn PM, Tuomanen EI, Rosch JW.

Cell Host Microbe. 2014 May 14;15(5):587-99. doi: 10.1016/j.chom.2014.04.005.

2.

Pneumococcus adapts to the sickle cell host.

Mitchell TJ, Mitchell AM.

Cell Host Microbe. 2014 May 14;15(5):521-3. doi: 10.1016/j.chom.2014.04.013.

3.

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Halasa NB, Shankar SM, Talbot TR, Arbogast PG, Mitchel EF, Wang WC, Schaffner W, Craig AS, Griffin MR.

Clin Infect Dis. 2007 Jun 1;44(11):1428-33. Epub 2007 Apr 18.

4.

[Following the serotypes of pneumococcal strains isolated in asplenic subjects].

Varon E.

Presse Med. 2003 Sep 6;32(28 Suppl):S24-6. French.

PMID:
14631643
5.
6.

Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.

McCavit TL, Quinn CT, Techasaensiri C, Rogers ZR.

J Pediatr. 2011 Mar;158(3):505-7. doi: 10.1016/j.jpeds.2010.11.025. Epub 2010 Dec 28. Erratum in: J Pediatr. 2011 May;158(5):867.

7.

Pneumococcal colonization in children with sickle cell disease [see comment].

Norris CF, Mahannah SR, Smith-Whitley K, Ohene-Frempong K, McGowan KL.

J Pediatr. 1996 Dec;129(6):821-7.

PMID:
8969723
8.

Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.

Obert CA, Miller ML, Montgomery J, Adamkiewicz T, Tuomanen EI.

Antimicrob Agents Chemother. 2007 Jan;51(1):386-9. Epub 2006 Oct 23.

9.

Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in nasopharyngeal cultures from patients with sickle cell disease.

Sakhalkar VS, Sarnaik SA, Asmar BI, Conner-Warren R, Shurney W, Abdel-Haq NM.

South Med J. 2001 Apr;94(4):401-4.

PMID:
11332906
10.

Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease.

Steele RW, Warrier R, Unkel PJ, Foch BJ, Howes RF, Shah S, Williams K, Moore S, Jue SJ.

J Pediatr. 1996 Apr;128(4):531-5.

PMID:
8618188
11.

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.

Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease.

J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.

PMID:
21679725
12.
13.

Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease.

Hord J, Byrd R, Stowe L, Windsor B, Smith-Whitley K.

J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):470-2.

PMID:
12218595
14.

Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants.

Andrade AL, Franco CM, Lamaro-Cardoso J, André MC, Oliveira LL, Kipnis A, Rocha CG, Andrade JG, Alves SL, Park IH, Nahm MH, Almeida SG, Brandileone MC.

J Infect. 2010 Oct;61(4):314-22. doi: 10.1016/j.jinf.2010.07.003. Epub 2010 Jul 14.

15.

Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.

Ellison AM, Ota KV, McGowan KL, Smith-Whitley K.

Pediatr Infect Dis J. 2012 May;31(5):534-6. doi: 10.1097/INF.0b013e3182480fed.

PMID:
22228232
16.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.

O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, Gootenberg JE, Nold JT, Eskenazi A, Snader SJ, Lederman HM.

Pediatrics. 2000 Nov;106(5):965-72.

PMID:
11061761
17.

Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK.

Park IH, Kim KH, Andrade AL, Briles DE, McDaniel LS, Nahm MH.

MBio. 2012 Apr 24;3(3). pii: e00035-12. doi: 10.1128/mBio.00035-12. Print 2012.

18.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
19.

Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010.

Cho EY, Lee H, Choi EH, Kim YJ, Eun BW, Cho YK, Kim YK, Jo DS, Lee HS, Lee J, Kim MN, Kim DS, Lee HJ.

Diagn Microbiol Infect Dis. 2014 Apr;78(4):481-6. doi: 10.1016/j.diagmicrobio.2013.12.016. Epub 2014 Jan 7.

PMID:
24529940
20.

Infections in sickle cell anemia: pathogenesis and control.

Overturf G, Powars D.

Tex Rep Biol Med. 1980-1981;40:283-92. Review.

PMID:
7034272
Items per page

Supplemental Content

Write to the Help Desk